Evidence map›Paper›PMID 28751937›Full record

ArticleOxidative medicine and cellular longevity2017

Myricitrin Modulates NADPH Oxidase-Dependent ROS Production to Inhibit Endotoxin-Mediated Inflammation by Blocking the JAK/STAT1 and NOX2/p47

Shimei Qi, Zunyong Feng, Qiang Li, Zhilin Qi, Yao Zhang

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Molecular medicine reports · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Triple targeting of mutant EGFRJournal of enzyme inhibition and medicinal chemistry · 2023
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shimei QiAnhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China.ORCID 0000-0003-1732-1751
Zunyong FengAnhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China.
Qiang LiAnhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China.
Zhilin QiAnhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China.ORCID 0000-0002-4968-551X
Yao ZhangAnhui Province Key Laboratory of Active Biological Macromolecules, Wannan Medical College, Wuhu, China.ORCID 0000-0003-3408-3556
Wannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myricitrin, a naturally occurring polyphenol hydroxy flavonoid, has been reported to possess anti-inflammatory properties. However, the precise molecular mechanism of myricitrin's effects on LPS-induced inflammation is unclear. In the present study, myricitrin significantly alleviated acute lung injury in mice. Myricitrin also markedly suppressed the production of NO, TNF-α, IL-6, and MCP-1 in RAW264.7 macrophage cells. The inhibition of NO was concomitant with a decrease in the protein and mRNA levels of iNOS. The phosphorylation of JAKs and STAT-1 was abrogated by myricitrin. Furthermore, myricitrin inhibited the nuclear transfer and DNA binding activity of STAT1. The JAK-specific inhibitor ruxolitinib simulated the anti-inflammatory effect of myricitrin. However, myricitrin had no impact on the MAPK signalling pathway. Myricitrin attenuated the generation of intracellular ROS by inhibiting the assembly of components of the gp91

Indexed as

AnimalsFlavonoidsJanus KinasesLipopolysaccharidesMiceNADPH Oxidase 2NADPH OxidasesRAW 264.7 CellsReactive Oxygen SpeciesSTAT1 Transcription FactorCybb protein, mouseFlavonoidsJanus KinasesLipopolysaccharidesmyricitrinNADPH Oxidase 2NADPH Oxidasesneutrophil cytosolic factor 1Reactive Oxygen SpeciesSTAT1 protein, humanSTAT1 Transcription Factor

Identifiers

PMID28751937
PMCPMC5496130
OpenAlexW2713908320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.